Fourth quarter and full year results 2014
5th February 2015, London
AstraZeneca will announce fourth quarter and full year results for 2014 on Thursday 5th February 2015. Presentations will be made by Pascal Soriot, Chief Executive Officer; Marc Dunoyer, Chief Financial Officer; Briggs Morrison, EVP Global Medicines Development and Luke Miels EVP GPPS, and will be followed by a live question and answer session.p>
Accounting for the US Branded Pharmaceutical Fee
AstraZeneca Investor Day
Third quarter and nine months results 2014
European Society for Medical Oncology (ESMO) 2014
Second quarter and half year results 2014
Annual Report 2013
Our Annual Report provides a wide range of information about our global business and how we are working, both within the company and in partnership with others, to push the boundaries of science and deliver medicines that transform the lives of people around the world.
Currency guidance 2014
In order to help analysts and investors estimate the impact of changing exchange rates on sales and earnings, the Company provides an annual 'currency sensitivity guide', alongside the rates upon which its earnings guidance is based.
The latest guide, intended to help estimate the impact of currency movements for 2014, is an update of the 2013 guidance given in January 2013.
Keeping investors in touch
AstraZeneca Investor Relations iPad app
The AstraZeneca Investor Relations iPad app provides instant access to our latest news, webcasts and presentations, events and leadership videos.
Notifications will keep you up to date with the most recent updates from AstraZeneca and synchronise to your device for reference.